P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/R...

por Garg, Mahek, Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine, Chakraborty, Samhita, Doshi, Jalpa, Huntington, Scott
Publicado 2023

15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficia...

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2021

Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2022

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries

por Doshi, Jalpa A, Jahnke, Jordan, Raman, Swathi, Puckett, Justin T, Brown, Victoria T, Ward, Melea Anne, Li, Pengxiang, Manz, Christopher R
Publicado 2021